After Uzbekistan Health Ministry alleged Indian company Marion Biotech cough syrup responsible for the death of 18 children, a joint inspection of the NOIDA facility of the manufacturer, Marion Biotech, was carried out by UP Drug Control and CDSCO team.
The Central Drugs Standard Control Organisation (CDSCO) is in regular contact with the national drug regulator of Uzbekistan regarding the matter.
“Immediately on receipt of the information, joint inspection of the NOIDA facility of the manufacturer, Marion Biotech, was carried out by UP Drug Control and CDSCO team and further action as appropriate would be initiated based on the inspection report”, said union health ministry on Thursday.
The samples of the cough syrup have been taken from the manufacturing premises and sent to Regional Drugs Testing Laboratory (RDTL), Chandigarh for testing. Meanwhile, Marion Biotech Pharma company has said that it has sent samples of the said cough syrup for testing and has also halted the production of the product. Marion Biotech is a licensed manufacturer and holds license for manufacturing of Dok1 Max syrup and Tablet for export purpose granted by Drugs Controller, Uttar Pradesh.
In a major advancement for the surgical landscape in India, Apollo Spectra Hospital has unveiled…
In an uncommon measure, doctors at a city hospital pulled off a 55-year patient with…
Rabies remains one of the most dangerous yet misunderstood viral diseases in the world. Despite…
Health experts have urged the public to clearly understand the difference between asthma-related breathing problems…
A three-day “Revision Arthroplasty Conference” (RAC 2025) which commenced on Friday in the national capital…
Under the Yellow Ribbon Campaign conceptualized in 1998 by Dr S K Sarin with the…